Updated Jul 16, 2026
Ben Zvi Shmuel is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Ben Zvi Shmuel is associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic proteins. Specific details about his role and contributions to the company are not widely documented in public sources.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-03 | PLX | Protalix BioTherapeutics, Inc. | A — Grant or award | 7.5K | — |
Ben Zvi Shmuel is associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic proteins. Specific details about his role and contributions to the company are not widely documented in public sources.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ben Zvi Shmuel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.